Clinical trial
CfDNA in Hereditary And High-risk Malignancies 2
NCT06726642
Study timeline
Study start (actual)2024-04-19Date precision: day
Registry last updated2025-12-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hereditary Cancer Syndromeunresolved
Interventions
Cell-free DNA analysisDIAGNOSTIC_TEST
Sponsors & collaborators
University Health Network, Torontolead sponsor
British Columbia Cancer Agencycollaborator
Eastern Healthcollaborator
IWK Health Centrecollaborator
Jewish General Hospitalcollaborator
Sinai Health Systemcollaborator
The Hospital for Sick Childrencollaborator
University of Albertacollaborator
Women's College Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06726642 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.